- Home
- VCTR vs TERN Comparison
VCTR vs TERN Comparison
Compare VCTR & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCTR | TERN |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.8B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCTR | TERN |
|---|---|---|
| Price | $63.65 | $47.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $73.33 | $48.60 |
| AVG Volume (30 Days) | 402.3K | ★ 4.9M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.90 | N/A |
| Revenue | ★ $1,164,380,000.00 | N/A |
| Revenue This Year | $48.52 | N/A |
| Revenue Next Year | $16.80 | N/A |
| P/E Ratio | $16.36 | ★ N/A |
| Revenue Growth | ★ 34.31 | N/A |
| 52 Week Low | $47.00 | $1.87 |
| 52 Week High | $73.00 | $48.26 |
Technical Indicators
Market Signals| Indicator | VCTR | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 87.85 |
| Support Level | $61.15 | $25.67 |
| Resistance Level | $64.11 | $48.26 |
| Average True Range (ATR) | 1.44 | 3.33 |
| MACD | 0.25 | 1.58 |
| Stochastic Oscillator | 81.38 | 96.34 |
Price Performance
Historical ComparisonAbout VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.